Roivant Sciences (ROIV) Shares Outstanding (Weighted Average) (2020 - 2026)

Roivant Sciences has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $693.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 4.35% year-over-year to $693.9 million; the trailing twelve-month figure through Mar 2026 stood at $693.9 million (down 4.35% YoY), and the FY2026 full-year result was $693.9 million, down 4.35% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $693.9 million, up from $686.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $800.6 million in Q4 2023, with the low at $20.5 million in Q3 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $680.6 million across 5 years, with a median of $712.8 million in 2023.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) jumped 3624.12% — and 2024, when it dropped 9.73%.
• Roivant Sciences' Shares Outstanding (Weighted Average) stood at $703.1 million in 2022, then advanced by 13.87% to $800.6 million in 2023, then fell by 9.73% to $722.7 million in 2024, then retreated by 5.07% to $686.1 million in 2025, then advanced by 1.14% to $693.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $693.9 million (Q1 2026), $686.1 million (Q4 2025), and $680.9 million (Q3 2025), per Business Quant data.